the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Catalog | E-mail Alert | Custom Research | About The Infoshop | Contact Us | Site Map |

* View All Categories
Japanese Korean Chinese

[Report]

Anti Infectives, Vol II: Antibacterials

Published: 2007/04

Contact 24 hrs/day
Description

Table of Contents

Executive Summary

  • Introduction
  • Scope and Methodology
  • Size and Growth of the Market
  • Issues and Trends Affecting Market
  • Leading Competitors

Introduction The World Market for Anti-Infectives Volume 2:

  • Antibacterial Drugs
  • Introduction to pathogens
    • Classification of Antibacterial Organisms
    • Antimicrobial Spectrum
    • Bacterial Resistance
    • Principles of Anti-infective Therapy
    • Infecting Organism
    • Antibiotic Sensitivity Testing
    • Site of Infection
    • Host Defenses and Organ Function
    • Antibiotic Pharmacokinetics
    • Monitoring Therapy
    • Combination Therapy and Prophylactic Use
  • Demographics and Statistics

Issues and Trends Affecting the Antibacterial Drug Market

  • introduction
  • Drug Resistance and Interactions
  • Antibiotic Abuse
  • Antibiotic Cycling
  • addressing market trends
  • Antibiotic use in Agriculture
  • Antibiotic Education
  • Children and Bacterial resistance
  • The Elderly and Bacterial Resistance
  • Compromised Individuals and Bacterial Resistance
  • Screening Hospitalized patients
  • Side Effects of Antibiotics
  • Partnerships and Alliances
  • Environment and Drug Resistance
  • Methicillin-resistant Staphylococcus Aureus (MRSA)

Cephalosporin Antibiotics

  • Overview
  • Description of Products
    • First Generation Cephalosporins
    • Cephalexin (Keflex, Advancis Pharmaceuticals)
    • Cefazolin (Ancef, GlaxoSmithKline; Cefamezin, Astellas)
    • Cefadroxil (Duricef, Bristol-Myers Squibb/Warner Chilcot)
    • Second Generation Cephalosporins
    • Cefuroxime (Ceftin, GlaxoSmithKline)
    • Cefoxitin (Mefoxin, Merck)
    • Third Generation Cephalosporins
    • Cefotaximen (Claforan offered by Sanofi-Aventis)
    • Cefoperazone (Cefobid, Pfizer)
    • Ceftibutin (Cedax, Shionogi)
    • Ceftizoxime (Cefizox, Astellas)
    • Ceftriaxone (Rocephin, Roche)
    • Ceftazidime (Fortaz, GlaxoSmithKline)
    • Cefixime (Suprax, Wyeth/Lupin Pharmaceuticals)
    • Cefpodoxime (Vantin, Pfizer)
    • Fourth Generation Cephalosporins
    • Cefepime (Maxipime, Bristol-Myers Squibb)
  • Generic Drug Impact and Availability
  • Research and Development
  • Market Size and Growth
  • Competitive Analysis

Macrolide Antibiotics

  • Overview
  • Description of Products
    • Azithromycin (Zithromax, Pfizer; Zmax, Pfizer)
    • Clarithromycin (Biaxin, Abbott Laboratories)
    • Erythromycin (Erythrocin, Abbott Laboratories; EryPed, Abbott Laboratories)
    • Telithromycin (Ketek, Sanofi-Aventis)
  • Generic Drug Impact and Availability
  • Research and Development
  • Market Size and Growth
  • Competitive Analysis

Penicillin Antibiotics

  • Overview
  • Natural Penicillins
  • Penicillinase-Resistant Penicillins
  • Broad -Spectrum Penicillins
  • Extended-Spectrum Penicillins

Description of Products

  • Natural Penicillins
  • Penicillin G (Bicillin, King Pharmaceuticals; Pfizerpen, Pfizer)
  • Penicillinase-resistant Penicillins
  • Cloxacillin (Cloxapen, GlaxoSmithKline)
  • Oxacillin (Bactocill, GlaxoSmithKline)
  • Broad-spectrum Penicillins
  • Amoxicillin (Augmentin, GlaxoSmithKline; Amoxil,GlaxoSmithKline)
  • Ampicillin (Unasyn, Pfizer)
  • Extended-spectrum Penicillins
  • Carbenicillin (Geocillin, Pfizer)
  • Piperacillin (Pipracil, Wyeth; Zosyn, Wyeth)
  • Ticarcillin (Timentin, GlaxoSmithKline)
  • Generic Drug Impact and Availability
  • Research and Development
  • Market Size and Growth
  • Competitive Analysis

Quinolone Antibiotics

  • Overview
  • Description of Products
    • Ciprofloxacin (Cipro, Bayer; Proquin XR, Depomed)
    • Gemifloxacin (Factive, LG Chem Ltd. and Oscient Pharmaceuticals)
    • Lomefloxacin (Maxaquin, Unimed)
    • Nalidixic (NegGram, Sanofi-Aventis)
    • Norfloxacin (Noroxin, Merck)
    • Ofloxacin (Floxin, Ortho-McNeil)
    • Moxifloxicin (Avelox, Bayer; Vigamox, Alcon)
    • Levofloxacin (Levaquin, Ortho-McNeil; Tavanic, Sanofi-Aventis; Cravit, Daiichi Sankyo; Quixin, Santen)
    • Gatifloxacin (Zymar, Allergan/Kyorin)
    • Trovafloxacin (Trovan, Pfizer)
  • Generic Drug Impact and Availability
  • Research and Development
  • Market Size and Growth
  • Competitive Analysis

Sulfonamide Antibiotics

  • Overview
  • Description of Products
  • Sulfisoxazole (Gantrisin Pediatric, Roche)
    • Oxytetracycline/Sulfamethizole/Phenazopyridine (Urobiotic, Pfizer)
    • Erythromycin ethylsuccinate and Sulfisoxazole acetyl (Pediazole, Ross)
    • Dapsone (Aczone Gel, QLT USA-Tolmar Inc.)
  • Research and Development
  • Market Size and Growth
  • Competitive Analysis

Tetracycline Antibiotics

  • Overview
  • Description of Products
  • Generic Drug Impact and Availability
  • Research and Development
  • Market Size and Growth
  • Competitive Analysis

Other Miscellaneous Antibiotics

  • Overview
  • Description of Products
  • Aminoglycosides
    • Amikacin Sulfate (Amikin, Bristol-Myers Squibb)
    • Kanamycin Sulfate (Kantrex, Bristol-Myers Squibb)
    • Neomycin Sulfate (Neo-fradin, X Gen Pharms)
    • Streptomycin Sulfate (Streptomycin, Pfizer)
    • Lincomycin
    • Clindamycin (Cleocin, Pfizer; Clindesse, KV Pharmaceutical Company; Evoclin, Connetics Corp.; Ziana Gel, Medicis/Dow)
    • Chloramphenicol
    • Chloramphenicol (Chloromycetin,Pfizer)
    • Glycopeptide
    • Vancomycin (Vancocin, Viropharma)
    • Monobactams
    • Aztreonam (Azactam, Bristol-Myers Squibb)
    • Carbapenems
    • Imipenem/cilastatin (Primaxin, Merck)
    • Meropenem (Merrem, AstraZeneca)
    • Metronidazole
    • Metronidazole (Flagyl, Pfizer; Pylera, Axcan; Metrogel-Vaginal, 3M Pharmaceuticals; MetroGel, Galderma)
    • Antituberculars
    • Rifampicin (Rifater, Sanofi-Aventis)
    • Capreomycin (Capastat sulfate, Eli Lilly & Co.)
    • Ethionamide (Trecator SC, Wyeth)
    • Aminosalicylic acid granules (Paser Granules, Jacobus Pharmaceutical)
    • Cycloserine (Seromycin, Eli Lilly & Co.)
    • Antileprotics
    • Dapsone (Dapsone, Jacobus)
    • Oxazolidinones
    • Linezolid (Zyvox, Pfizer)
    • Ketolides
    • Telithromycin (Ketek, Sanofi-Aventis)
    • Lipopeptides
    • Daptomycin (Cubicin, Cubist Pharmaceutical)
    • Glycyclines
    • Tigecycline (Tygacil, Wyeth)
    • Generic Drug Impact and Availability
    • Research and Development
    • Market Size and Growth
    • Competitive Analysis

Corporate Profiles

  • Introduction
  • Abbott Laboratories
  • AstraZeneca plc
  • Bayer Schering Pharma AG
  • Cubist Pharmaceuticals, Inc
  • Daiichi Sankyo Co., Ltd.
  • GlaxoSmithKline
  • Johnson & Johnson Group
  • King Pharmaceuticals, Inc.
  • Merck & Company, Inc.
  • Pfizer, Inc.
  • Roche
  • Sanofi-Aventis
  • Wyeth

Company Names and Addresses

Description

[Report]
Anti Infectives, Vol II: Antibacterials
Published: 2007/04
Published by : Kalorama Information Kalorama Information

Price:
US $ 2,995.00 PDF by E-mail (Single User License)
US $ 3,395.00 Hard Copy
US $ 3,795.00 PDF by E-mail (Single User License) & Hard Copy
US $ 5,990.00 PDF by E-mail (Global Site License)
>
Product Code : KL50805
Please inform me when related publications are released
InfoWatch

Available 24 Hours a Day
US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2008, the-infoshop.com by Global Information, Inc. All rights reserved.